A pair of drugs that use the immune system to attack cancer cells shrunk tumours in nearly 60 per cent of people with advanced melanoma according to a recent study in the U.K. — though questions about survival, side-effects and cost remain.
from CBC | Health News http://ift.tt/1FZ4nRK
ABOUT THE AUTHOR
Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible
0 commentaires:
Enregistrer un commentaire